Clinical Trial Update: Evaluate the Safety and Clinical Activity of HH2853 [Phase 1, Phase 2]

View source ↗

Summary

The trial update indicates HH2853 is being studied in Phase 1/Phase 2 across follicular lymphoma, epithelioid sarcoma, peripheral T-cell lymphoma, and advanced …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Epithelioid Sarcoma
• Follicular Lymphoma
• Peripheral T-cell Lymphoma
• Solid Tumor

Drugs mentioned

• HH2853

Snippet

Sponsor: Haihe Biopharma Co., Ltd. | Conditions: FL Lymphoma, Epithelioid Sarcoma | Phase 1, Phase 2 | Status: RECRUITING